PreGen-26 colorectal cancer test regulatory update

EXAS received U.S. Patent No. 6,280,947 covering the detection of nucleotide insertions or deletions at the BAT-26 locus, which EXAS said occurs in 90% of patients with hereditary non-polyposis colore...